BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22434643)

  • 21. Sulfides impair short chain fatty acid beta-oxidation at acyl-CoA dehydrogenase level in colonocytes: implications for ulcerative colitis.
    Babidge W; Millard S; Roediger W
    Mol Cell Biochem; 1998 Apr; 181(1-2):117-24. PubMed ID: 9562248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism.
    Finnie IA; Taylor BA; Rhodes JM
    Gut; 1993 Nov; 34(11):1552-8. PubMed ID: 8244143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Butyrate absorption and lactate secretion in ulcerative colitis.
    Hove H; Holtug K; Jeppesen PB; Mortensen PB
    Dis Colon Rectum; 1995 May; 38(5):519-25. PubMed ID: 7736884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis?
    Roediger WE; Duncan A; Kapaniris O; Millard S
    Clin Sci (Lond); 1993 Nov; 85(5):623-7. PubMed ID: 8287651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis.
    Den Hond E; Hiele M; Evenepoel P; Peeters M; Ghoos Y; Rutgeerts P
    Gastroenterology; 1998 Sep; 115(3):584-90. PubMed ID: 9721155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced Mucosa-associated Butyricicoccus Activity in Patients with Ulcerative Colitis Correlates with Aberrant Claudin-1 Expression.
    Devriese S; Eeckhaut V; Geirnaert A; Van den Bossche L; Hindryckx P; Van de Wiele T; Van Immerseel F; Ducatelle R; De Vos M; Laukens D
    J Crohns Colitis; 2017 Feb; 11(2):229-236. PubMed ID: 27484096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of multiple transglutaminases in human colon: impaired keratinocyte transglutaminase expression in ulcerative colitis.
    D'Argenio G; Calvani M; Della Valle N; Cosenza V; Di Matteo G; Giorgio P; Margarucci S; Petillo O; Jori FP; Galderisi U; Peluso G
    Gut; 2005 Apr; 54(4):496-502. PubMed ID: 15753534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infliximab therapy decreases the levels of TNF-alpha and IFN-gamma mRNA in colonic mucosa of ulcerative colitis.
    Olsen T; Cui G; Goll R; Husebekk A; Florholmen J
    Scand J Gastroenterol; 2009; 44(6):727-35. PubMed ID: 19294580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis.
    Jørgensen J; Mortensen PB
    Dig Dis Sci; 2001 Aug; 46(8):1722-32. PubMed ID: 11508674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative Network-based Analysis of Colonic Detoxification Gene Expression in Ulcerative Colitis According to Smoking Status.
    Ding YP; Ladeiro Y; Morilla I; Bouhnik Y; Marah A; Zaag H; Cazals-Hatem D; Seksik P; Daniel F; Hugot JP; Wainrib G; Tréton X; Ogier-Denis E
    J Crohns Colitis; 2017 Apr; 11(4):474-484. PubMed ID: 27702825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis.
    Rismo R; Olsen T; Cui G; Christiansen I; Florholmen J; Goll R
    Scand J Gastroenterol; 2012 May; 47(5):538-47. PubMed ID: 22486187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.
    Arijs I; Li K; Toedter G; Quintens R; Van Lommel L; Van Steen K; Leemans P; De Hertogh G; Lemaire K; Ferrante M; Schnitzler F; Thorrez L; Ma K; Song XY; Marano C; Van Assche G; Vermeire S; Geboes K; Schuit F; Baribaud F; Rutgeerts P
    Gut; 2009 Dec; 58(12):1612-9. PubMed ID: 19700435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Butyrate Does Not Protect Against Inflammation-induced Loss of Epithelial Barrier Function and Cytokine Production in Primary Cell Monolayers From Patients With Ulcerative Colitis.
    Vancamelbeke M; Laeremans T; Vanhove W; Arnauts K; Ramalho AS; Farré R; Cleynen I; Ferrante M; Vermeire S
    J Crohns Colitis; 2019 Sep; 13(10):1351-1361. PubMed ID: 30919886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of lipocalin-type-prostaglandin D synthase in ulcerative colitis and exacerbating role in murine colitis.
    Hokari R; Kurihara C; Nagata N; Aritake K; Okada Y; Watanabe C; Komoto S; Nakamura M; Kawaguchi A; Nagao S; Urade Y; Miura S
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G401-8. PubMed ID: 21163901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis.
    Toedter G; Li K; Marano C; Ma K; Sague S; Huang CC; Song XY; Rutgeerts P; Baribaud F
    Am J Gastroenterol; 2011 Jul; 106(7):1272-80. PubMed ID: 21448149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal nicotine decreases mucosal IL-8 expression but has no effect on mucin gene expression in ulcerative colitis.
    Louvet B; Buisine MP; Desreumaux P; Tremaine WJ; Aubert JP; Porchet N; Capron M; Cortot A; Colombel JF; Sandborn WJ
    Inflamm Bowel Dis; 1999 Aug; 5(3):174-81. PubMed ID: 10453373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis.
    de Bruyn M; Arijs I; Wollants WJ; Machiels K; Van Steen K; Van Assche G; Ferrante M; Rutgeerts P; Vermeire S; Opdenakker G
    Inflamm Bowel Dis; 2014 Jul; 20(7):1198-207. PubMed ID: 24871805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis.
    Vieira EL; Leonel AJ; Sad AP; Beltrão NR; Costa TF; Ferreira TM; Gomes-Santos AC; Faria AM; Peluzio MC; Cara DC; Alvarez-Leite JI
    J Nutr Biochem; 2012 May; 23(5):430-6. PubMed ID: 21658926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis.
    Chatzaki E; Anton PA; Million M; Lambropoulou M; Constantinidis T; Kolios G; Taché Y; Grigoriadis DE
    World J Gastroenterol; 2013 Mar; 19(9):1416-23. PubMed ID: 23539366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma.
    Toiyama Y; Mizoguchi A; Kimura K; Araki T; Yoshiyama S; Sakaguchi K; Miki C; Kusunoki M
    World J Gastroenterol; 2005 Sep; 11(33):5151-5. PubMed ID: 16127744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.